Every 10-Q that Ingevity Corporation (NGVT) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow NGVT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NGVT filings page.
Ingevity Corporation reported second‑quarter 2026 net sales of $314.1 million and net income from continuing operations of $39.8 million, compared with a loss a year earlier that had included a large goodwill impairment. Including discontinued operations, net income was $35.3 million for the quarter and $95.1 million year‑to‑date.
Results reflect portfolio changes and significant special items. The company completed the all‑cash sale of its industrial specialties product line, classified as discontinued operations, recognizing a $54.2 million gain, and sold its road markings product line for $63.2 million, recording an $8.6 million gain in continuing operations. In the Advanced Polymer Technologies segment, a sale process triggered a fair‑value review and a $32.1 million non‑cash long‑lived asset impairment. Segment EBITDA for the quarter totaled $122.7 million, led by Performance Materials at $86.1 million.
Operating activities used $15.8 million of cash in the first half, largely due to a $113.2 million litigation settlement payment to BASF related to prior antitrust counterclaims. Investing activities provided $181.7 million, mainly from divestiture and restricted investment proceeds. Total debt including finance leases was $1,202.8 million, with net leverage of 2.5 and interest coverage of 6.8 under credit‑agreement definitions. The company repurchased 1,265,189 shares for $87.4 million under its $500.0 million authorization.
Ingevity Corporation reported higher first‑quarter 2026 earnings, driven by a major divestiture gain despite significant litigation charges. Net sales from continuing operations rose to $258.0 million from $247.9 million, as better pricing and mix in Performance Materials and pavement technologies offset flat volumes.
Net income from continuing operations declined to $23.4 million from $29.1 million, mainly because of a $16.2 million litigation charge tied to the BASF antitrust verdict and related costs. Including discontinued operations, total net income increased to $59.8 million, helped by a $55.6 million gain on the sale of the industrial specialties product line and crude tall oil refinery, which generated $93.1 million of cash proceeds.
Performance Materials segment EBITDA grew to $92.0 million on stronger pricing, mix and utilization, while Performance Chemicals segment EBITDA fell to $0.6 million amid weaker road markings performance. Ingevity ended the quarter with $95.4 million in cash and $1.21 billion of debt and amended its revolving credit facility, reducing commitments to $750 million and extending maturity to 2031.
Ingevity Corporation (NGVT) reported steady Q3 2025 results. Net sales were $333.1 million versus $333.8 million a year ago, and gross profit rose to $133.9 million from $131.6 million. Income from continuing operations before taxes was $62.2 million (vs. $54.0 million), with net income of $43.5 million. Diluted EPS was $1.18 versus $(2.94), reflecting a large discontinued-operations loss in the prior year. The effective tax rate was 34.4%.
Year‑to‑date, net sales were $912.5 million (vs. $936.8 million) and net loss was $(82.5) million, driven by a non‑cash $183.8 million goodwill impairment in Advanced Polymer Technologies. Operating cash flow improved to $234.1 million (vs. $64.1 million). Total debt including finance leases declined to $1.2639 billion from $1.4052 billion, and interest expense fell to $56.4 million (vs. $69.3 million). Revolver covenants remained comfortable, with net leverage at 2.7x and interest coverage at 5.5x.
The company signed an Asset Purchase Agreement on September 3, 2025 to divest its industrial specialties product line and North Charleston CTO refinery, which are presented as discontinued operations; closing is expected by early 2026. During Q3, NGVT repurchased $25.2 million of stock, or 445,724 shares at a weighted average of $56.09.